Profile
BDXA ISRG BDX ALC RMD MDLN
Company Name Becton, Dickinson and Company Intuitive Surgical, Inc. Becton, Dickinson and Company Alcon Inc. ResMed Inc. Medline Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $55.91B $173.36B $59.94B $39.26B $37.85B $36.29B
Employees 0.00K 15.64K 70.00K 25.60K 9.98K 43.00K
CEO - David J. Rosa Thomas E. Polen Jr. David J. Endicott Michael J. Farrell James Boyle
Ratings
BDXA ISRG BDX ALC RMD MDLN
Quant Rating Score 5 1 3 3 4 3
Quant Rating Strong Buy Strong Sell Neutral Neutral Buy Neutral
Trading
BDXA ISRG BDX ALC RMD MDLN
Last Close $59.24 $546.71 $190.98 $76.61 $244.71 -
High 52 $59.24 $610.45 $249.08 $98.3 $293.73 -
Low 52 $59.24 $429.59 $165.15 $72.05 $204.58 -
Price vs. 52 Week High 0 % -10.44 % -23.33 % -22.07 % -16.69 % -
Price vs. 52 Week Low 0 % 27.26 % 15.64 % 6.33 % 19.62 % -
Total Return
BDXA ISRG BDX ALC RMD MDLN
1 Month Return 0 % 22.54 % 0.99 % 2 % -8.72 % -
3 Month Return 0 % 13.64 % -2.06 % -13.07 % -14.47 % -
6 Month Return 0 % -3 % 8.88 % -14.72 % -2.77 % -
9 Month Return 0 % -9.02 % -15.17 % -14.35 % 6.13 % -
YTD Return 0 % 4.74 % -15.82 % -9.75 % 7.01 % -
1 Year Return 0 % 1.46 % -14.22 % -10.32 % 2.77 % -
3 Year Return 0 % 0 % 0 % 0 % 0 % -
5 Year Return 0 % 0 % 0 % 0 % 0 % -
Dividends
BDXA ISRG BDX ALC RMD MDLN
Dividend Yield Percentage (TTM) 1.99 % - 1.99 % 0.42 % 0.87 % -
Dividend Paid and Capex Coverage Ration (TTM) 1.75 % 4.3 % 1.75 % 3.02 % 4.31 % 6.53 %
Dividend Per Share (TTM) 4.17 % - 4.17 % 0.33 % 2.26 % -
Payout Ratio (TTM) 71.28 % - 71.28 % 15.49 % 22.31 % -
Profitability
BDXA ISRG BDX ALC RMD MDLN
Gross Profit Margin TTM 45.44 % 66.06 % 45.44 % 55.12 % 60.08 % 24.48 %
Return on Assets TTM 3.03 % 14.76 % 3.03 % 3.32 % 17.31 % 1.78 %
Return on Equity TTM 6.63 % 16.72 % 6.63 % 4.77 % 25.13 % 3.84 %
Return on Capital Employed TTM 5.48 % 16.78 % 5.48 % 5.06 % 24.74 % 3.51 %
Net Income Per EBT TTM 89.16 % 86.25 % 89.16 % 84.1 % 82.6 % 93.04 %
EBT Per Ebit TTM 73 % 112.42 % 73 % 86.34 % 99.79 % 58.52 %
EBIT Per Revenue TTM 11.8 % 29.27 % 11.8 % 14.16 % 33.18 % 8.59 %
Cash Flow To Debt Ratio TTM 17.88 % - 17.88 % 39.18 % 222.53 % 8.16 %
Receivables Turnover TTM 7.29 7.27 7.29 5.26 5.49 4.09
Payables Turnover TTM - 11.73 - 5.11 7.87 10.68
Inventory Turnover TTM 3.06 1.92 3.06 1.88 2.22 2.23
Fixed Asset Turnover TTM 312.12 % 195.4 % 312.12 % 198.09 % 724.52 % 298.53 %
Asset Turnover TTM 39.47 % 52.01 % 39.47 % 32.34 % 63.28 % 37.96 %
Operating Cash Flow Per Share TTM 11.97 8.34 11.97 4.16 12.86 1.73
Free Cash Flow Per Share TTM 9.32 6.4 9.32 3.11 12.06 1.46
Cash Per Share TTM 299.71 % 1383.15 % 299.71 % 303.41 % 944.79 % 121.33 %
Operating Cash Flow Sales Ratio TTM 15.71 % 29.42 % 15.71 % 20.13 % 35.82 % 9.7 %
Free Cash Flow Operating Cash Flow Ratio TTM 77.84 % 76.72 % 77.84 % 74.75 % 93.83 % 84.68 %
Cash Flow Coverage Ratios TTM 17.88 % - 17.88 % 39.18 % 222.53 % 8.16 %
Price To Free Cash Flows Ratio TTM 22.41 76.32 22.45 25.61 21.42 31.55
Price To Operating Cash Flows Ratio TTM 17.55 58.52 17.55 19.09 20.16 25.92
Price Cash Flow Ratio TTM 17.55 58.52 17.55 19.09 20.16 25.92
Income Statement (TTM)
BDXA ISRG BDX ALC RMD MDLN
Revenue $21.84B $10.06B $21.84B $9.91B $5.15B $25.51B
Gross Profit $9.92B $6.66B $9.92B $5.51B $3.05B $6.29B
Gross Profit Ratio 45.44% 66.13% 45.44% 55.61% 59.36% 24.66%
EBITDA $4.96B $3.31B $4.96B $2.68B $1.91B $3.53B
Net Income $1.68B $2.86B $1.68B $1.02B $1.4B $1.2B
EPS Diluted 5.83 7.87 5.83 2.05 9.51 1.52
Balance Sheet (MRQ)
BDXA ISRG BDX ALC RMD MDLN
Long Term Debt $17.62B $0.11B $17.62B $4.97B $0.81B $16.75B
Total Liabilities $29.94B $2.31B $29.94B $8.79B $2.21B $19.45B
Total Equity $25.39B $16.53B $25.39B $21.55B $5.97B $16.52B
Total Investments $0.01B $7.05B $0.01B $0.91B $0.09B $0.05B
Total Debt $19.18B $0.15B $19.18B $5.14B $0.85B $16.9B
Total Assets $55.33B $18.84B $55.33B $30.35B $8.17B $35.98B
Cash Flow Statement (TTM)
BDXA ISRG BDX ALC RMD MDLN
Net Income $1.68B $2.34B $1.68B $1.02B $1.4B $1.2B
Inventory $-0.41B $-0.83B $-0.41B $-0.05B $-0.08B $-0.55B
Dividends Paid $-1.2B $0B $-1.2B $-0.13B $-0.31B $0B
Operating Cash Flow $3.43B $2.42B $3.43B $2.08B $1.75B $1.77B
Capital Expenditure $-0.76B $-1.11B $-0.76B $-0.67B $-0.09B $-0.36B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 80.48
ANGO AngioDynamics, Inc. 11.02
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 140.17
ATRC AtriCure, Inc. 37.86
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AVTR Avantor, Inc. 11.16
AZTA Azenta, Inc. 29.99
BAX Baxter International Inc. 21.94
BDX Becton, Dickinson and Company 171.68
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 17.15
BLFS BioLife Solutions, Inc. 22.65
COO The Cooper Companies, Inc. 81.57
DXR Daxor Corporation 12.2
EKSO Ekso Bionics Holdings, Inc. 9.84
FEMY Femasys Inc. 0.5106
Unlock